Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Dolutegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients

NCT01837277 is registered in ClinicalTrials.gov with Fundação Bahiana de Infectologia as lead sponsor.

NCT NCT01837277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01837277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Dolutegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients
Lead sponsor
Fundação Bahiana de Infectologia
Phase
Phase 2/3
Overall status
Completed
Start date
December 15, 2017
Completion date
September 30, 2021
Enrollment
186 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

severely immunocompromised hiv patients